跳至主要内容
临床试验/NCT04058899
NCT04058899Unknown1 期

Dexmedetomidine Versus Nalbuphine in Prevention of Emergence Agitation Following Adenotonsillectomy in Pediatrics

Ain Shams University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2019年3月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
入组人数
120
试验地点
1
主要终点
postoperative agitation prevention in pediatrics after adenotonsillectomy under sevoflurane anesthesia

研究概览

简要总结

The aim of the present study is to compare the effect of IV infusion 0.5 µg/kg dexmedetomidine and IV 0.1 mg/kg nalbuphine in preschool children for prevention of emergence agitation after adenotonsillectomy under sevoflurane anesthesia.

详细描述

Consent will be obtained from legal guardian of children,patients will be randomized according to computer randomization to one of two groups, dexmedetomidine group (DEX)group who will receive 0.5 µg/kg dexmedetomidine diluted in 50 ml of normal saline 0.9% to be given by IV infusion over 10 minutes after induction of anesthesia then 5ml of 0.9% normal saline IV ,nalbuphine group (NAL)group will receive IV infusion of 50 ml of 0,9%normal saline by IV infusion over 10 minutes then 0.1mg/kg nalbuphine diluted in 5ml of 0.9%normal saline IV after induction of anesthesia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
2 Years 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children of (American Society of Anesthesiologist)ASA physical status grade I or II.
  • Aged 2-5 years
  • Undergoing elective adenotonsillectomy.

排除标准

  • History of hypersensitivity to the studied drug.
  • Refusal of the legal guardian to participate in the study.
  • Severely agitated child at induction of anesthesia
  • Occurrence of postoperative bleeding at(Post Anesthesia Care Unit) PACU

研究组 & 干预措施

, Dexmedetomidine group(DEX group)

Active Comparator

dexmedetomidine group (DEX)group who will receive 0.5 µg/kg dexmedetomidine diluted in 50 ml of normal saline 0.9% to be given by IV infusion over 10 minutes after induction of anesthesa then 5ml of 0.9% normal saline IV ,

干预措施: Dexmedetomidine (Drug)

, Dexmedetomidine group(DEX group)

Active Comparator

dexmedetomidine group (DEX)group who will receive 0.5 µg/kg dexmedetomidine diluted in 50 ml of normal saline 0.9% to be given by IV infusion over 10 minutes after induction of anesthesa then 5ml of 0.9% normal saline IV ,

干预措施: infusion pump (Device)

Nalbuphine group(NAL group)

Active Comparator

nalbuphine group (NAL)group will receive IV infusion of 50 ml of 0,9%normal saline by IV infusion over 10 minutes then 0.1mg/kg nalbuphine diluted in 5ml of 0.9%normal saline IV after induction of anesthesia.

干预措施: Nalbuphine (Drug)

Nalbuphine group(NAL group)

Active Comparator

nalbuphine group (NAL)group will receive IV infusion of 50 ml of 0,9%normal saline by IV infusion over 10 minutes then 0.1mg/kg nalbuphine diluted in 5ml of 0.9%normal saline IV after induction of anesthesia.

干预措施: infusion pump (Device)

结局指标

主要结局

postoperative agitation prevention in pediatrics after adenotonsillectomy under sevoflurane anesthesia

时间窗: stay in postoperative care unit till discharge of patient to ward.Time frame is up to 24 weeks

during stay in postoperative care unit using pediatric anesthesia emergence delirium score (PAED) as score equal or more than 16/20 is considered presence of agitation. during stay in postanesthesia care unit,score will be documented every 10 minutes by recovery staff.

次要结局

  • sedation in early postopertive time during child stay in postanesthesia care unit(stay in postoperative care unit till discharge of patient to ward.Time frame is up to 24 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ashraf Elsayed Elagamy

Assisstant proffesor

Ain Shams University

研究点 (1)

Loading locations...

相似试验